PA
XBI icon

PFG Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

PFG Advisors’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,382
Closed -$1.17M – 790
2025
Q1 		$1.17M Sell
14,382
-5,681
-28% -$508K 0.07% 304
2024
Q4 		$1.81M Sell
20,063
-70,774
-78% -$6.86M 0.11% 204
2024
Q3 		$8.97M Buy
90,837
+12,495
+16% +$1.23M 0.57% 42
2024
Q2 		$7.26M Buy
78,342
+5,018
+7% +$450K 0.49% 48
2024
Q1 		$6.96M Buy
73,324
+69,132
+1,649% +$6.41M 0.51% 46
2023
Q4 		$374K Buy
4,192
+66
+2% +$4.9K 0.03% 423
2023
Q3 		$301K Buy
4,126
+45
+1% +$3.6K 0.03% 456
2023
Q2 		$340K Sell
4,081
-2,048
-33% -$171K 0.03% 481
2023
Q1 		$467K Sell
6,129
-314
-5% -$26.1K 0.04% 398
2022
Q4 		$535K Sell
6,443
-22
-0.3% -$1.78K 0.05% 342
2022
Q3 		$513K Buy
6,465
+130
+2% +$11K 0.06% 317
2022
Q2 		$471K Buy
6,335
+501
+9% +$37.6K 0.05% 255
2022
Q1 		$524K Buy
5,834
+295
+5% +$27.2K 0.05% 259
2021
Q4 		$620K Sell
5,539
-496
-8% -$59.8K 0.06% 322
2021
Q3 		$759K Buy
6,035
+804
+15% +$104K 0.08% 285
2021
Q2 		$708K Buy
5,231
+815
+18% +$107K 0.08% 274
2021
Q1 		$599K Buy
4,416
+590
+15% +$88.3K 0.08% 270
2020
Q4 		$539K Buy
3,826
+103
+3% +$13.2K 0.09% 235
2020
Q3 		$441K Buy
+3,723
New +$417K 0.08% 243

Other funds holding XBI

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PFG Advisors's XBI Position: Q2 2025 in Review

PFG Advisors sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 14,382 shares — an estimated $1.17M sold.

PFG Advisors first reported a position in XBI in Q3 2020 and held it in 19 quarters. The position peaked at $8.97M in Q3 2024. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

  • PFG Advisors reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
  • PFG Advisors sold 14,382 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $1.17M.
  • PFG Advisors first reported a position in State Street SPDR S&P Biotech ETF in Q3 2020 and held it in 19 quarters.
  • PFG Advisors's State Street SPDR S&P Biotech ETF position peaked at $8.97M in Q3 2024.
  • 625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on PFG Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.